Search for Clinical Trial Results

Essential Thrombocythemia - 25 Studies Found
Status | Study |
Completed |
Study Name: Anagrelide Retard in Essential Thrombocythemia Condition: Essential Thrombocythemia Date: 2014-02-13 Interventions:
|
Not yet recruiting |
Study Name: Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea Condition: Essential Thrombocythemia Date: 2017-04-17 Interventions:
|
Completed |
Study Name: French Observational Xagrid (FOX) Study In Adult Patients With Essential Thrombocythemia Condition: Essential Thrombocythemia Date: 2010-08-26 |
Completed |
Study Name: Anagrelide vs. Hydroxyurea - Efficacy and Tolerability Study in Patients With Essential Thrombocythaemia Condition: Essential Thrombocythaemia Date: 2010-02-08 Interventions:
|
Completed |
Study Name: The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET) Condition: Essential Thrombocythaemia Date: 2006-12-19 Interventions: Drug: anagrelide hydrochloride Anagrelide hydrochloride 0.5 mg per capsule; patients will be stable on a |
Completed |
Study Name: Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia Condition: Essential Thrombocythaemia Date: 2010-10-28 Interventions:
|
Completed |
Study Name: Pediatric Disease Registry in Essential Thrombocythaemia (ET) Condition: Essential Thrombocythemia (ET) Date: 2010-09-08 |
Completed |
Study Name: Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia Condition: Essential Thrombocythemia (ET) Date: 2011-10-31 Interventions: Drug: SPD422 (anagrelide hydrochloride) Subjects will be continued on the dose of anagrelide that contro |
Not yet recruiting |
Study Name: Hydroxyurea Versus Aspirin and Hydroxyurea in Essential Thrombocythemia Condition:
Date: 2015-10-13 Interventions:
|
Recruiting |
Study Name: Myelofibrosis and Essential Thrombocythemia Observational Study (MOST) Condition:
Date: 2016-11-01 |